Literature DB >> 14209776

PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.

G K AGHAJANIAN, O H BING.   

Abstract

Entities:  

Keywords:  BLOOD CHEMICAL ANALYSIS; INJECTIONS, INTRAVENOUS; LYSERGIC ACID DIETHYLAMIDE; METABOLISM

Mesh：

Substances：

Year:  1964        PMID： 14209776     DOI： 10.1002/cpt196455611

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects.

Authors:  Friederike Holze; Urs Duthaler; Patrick Vizeli; Felix Müller; Stefan Borgwardt; Matthias E Liechti
Journal:  Br J Clin Pharmacol       Date:  2019-04-29       Impact factor: 4.335

2.  The stimulus properties of LSD in C57BL/6 mice.

Authors:  J C Winter; A K Kieres; M D Zimmerman; C J Reissig; J R Eckler; T Ullrich; K C Rice; R A Rabin; J B Richards
Journal:  Pharmacol Biochem Behav       Date:  2005-08       Impact factor: 3.533

3.  Use of anti-epileptic medication in treating "flashbacks" from hallucinogenic drugs.

Authors:  H J Thurlow; J P Girvin
Journal:  Can Med Assoc J       Date:  1971-11       Impact factor: 8.262

4.  Coma, hyperthermia and bleeding associated with massive LSD overdose. A report of eight cases.

Authors:  J C Klock; U Boerner; C E Becker
Journal:  West J Med       Date:  1974-03

5.  Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans.

Authors:  Patrick C Dolder; Yasmin Schmid; Manuel Haschke; Katharina M Rentsch; Matthias E Liechti
Journal:  Int J Neuropsychopharmacol       Date:  2015-06-24       Impact factor: 5.176

6.  Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.

Authors:  Patrick C Dolder; Yasmin Schmid; Andrea E Steuer; Thomas Kraemer; Katharina M Rentsch; Felix Hammann; Matthias E Liechti
Journal:  Clin Pharmacokinet       Date:  2017-10       Impact factor: 6.447

7.  Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).

Authors:  Adam L Halberstadt; Muhammad Chatha; Adam K Klein; John D McCorvy; Markus R Meyer; Lea Wagmann; Alexander Stratford; Simon D Brandt
Journal:  Neuropharmacology       Date:  2019-11-19       Impact factor: 5.273

Review 8.  Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.

Authors:  Attila Szabo
Journal:  Front Immunol       Date:  2015-07-14       Impact factor: 7.561

9.  Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.

Authors:  Friederike Holze; Matthias E Liechti; Nadia R P W Hutten; Natasha L Mason; Patrick C Dolder; Eef L Theunissen; Urs Duthaler; Amanda Feilding; Johannes G Ramaekers; Kim P C Kuypers
Journal:  Clin Pharmacol Ther       Date:  2020-10-18       Impact factor: 6.875
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.